Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury,…
| Price | $1.49 |
|---|---|
| Market cap | $57.38M |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Exchange | AMEX |
| 52-week range | 0.605-1.885 |
| Beta | 1.5 |
Explore MYO's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.